CCE
2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM
Created: | 2004-01-15 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 1 |
Atom Count | 25 |
Chiral Atom Count | 0 |
Bond Count | 24 |
Aromatic Bond Count | 0 |
Chemical Component Summary | |
---|---|
Name | 2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM |
Synonyms | CARBAMYL-CHOLINE |
Systematic Name (OpenEye OEToolkits) | 2-aminocarbonyloxyethyl-trimethyl-azanium |
Formula | C6 H15 N2 O2 |
Molecular Weight | 147.195 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(OCC[N+](C)(C)C)N |
SMILES | CACTVS | 3.341 | C[N+](C)(C)CCOC(N)=O |
SMILES | OpenEye OEToolkits | 1.5.0 | C[N+](C)(C)CCOC(=O)N |
Canonical SMILES | CACTVS | 3.341 | C[N+](C)(C)CCOC(N)=O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | C[N+](C)(C)CCOC(=O)N |
InChI | InChI | 1.03 | InChI=1S/C6H14N2O2/c1-8(2,3)4-5-10-6(7)9/h4-5H2,1-3H3,(H-,7,9)/p+1 |
InChIKey | InChI | 1.03 | VPJXQGSRWJZDOB-UHFFFAOYSA-O |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank ID | DB00411 |
---|---|
Name | Carbamoylcholine |
Groups | approved |
Description | Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932.[A226315] Carbamoylcholine was initially used as a treatment for migraines,[A226365] induction of diuresis,[A226370] and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.[L30245] |
Synonyms |
|
Brand Names |
|
Indication | Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.[L30245] |
Categories |
|
ATC-Code |
|
CAS number | 462-58-8 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Muscarinic acetylcholine receptor M1 | MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF... | unknown | agonist |
Muscarinic acetylcholine receptor M2 | MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV... | unknown | agonist |
Neuronal acetylcholine receptor subunit alpha-2 | MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALP... | unknown | agonist |
Muscarinic acetylcholine receptor M3 | MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFS... | unknown | agonist |
Muscarinic acetylcholine receptor M4 | MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGN... | unknown | agonist |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL965 |
PubChem | 2551 |
ChEMBL | CHEMBL965 |
CCDC/CSD | CBMCHL01, CBCHOL01, CBMCHL10, CMCHOL01, CBCHOL10, CBCPIC |